Fatigue in Parkinson's disease: Italian validation of the Parkinson Fatigue Scale and the Fatigue Severity Scale using a Rasch analysis approach

被引:26
|
作者
Siciliano, M. [1 ,2 ]
Chiorri, C. [3 ]
De Micco, R. [1 ]
Russo, A. [1 ]
Tedeschi, G. [1 ]
Trojano, L. [2 ]
Tessitore, A. [1 ]
机构
[1] Univ Campania Luigi Vanvitelli, MRI Res Ctr SUN FISM, Dept Adv Med & Surg Sci, Piazza Miraglia 2, I-80138 Naples, Italy
[2] Univ Campania Luigi Vanvitelli, Dept Psychol, Viale Ellittico 31, Caserta, Italy
[3] Univ Genoa, Dept Educ Sci, Genoa, Italy
关键词
Fatigue; Rasch analysis; Fatigue Severity Scale; Parkinson Fatigue Scale; Parkinson's disease; Italian version; MULTIPLE-SCLEROSIS; NONMOTOR SYMPTOMS; VERSION; APATHY; ASSOCIATION;
D O I
10.1016/j.parkreldis.2019.05.028
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The Fatigue Severity Scale (FSS-9) and the Parkinson Fatigue Scale (PFS-16) are commonly used for assessing fatigue in Parkinson's disease (PD). Here we validated the Italian version of these scales, assessed their psychometric properties by Rasch analysis, and computed their optimal cut-off scores using clinical diagnosis of PD-related fatigue as the gold standard. Methods: PD patients (n = 167) completed the Italian versions of FSS-9 and PFS-16. Each item of PFS-16 was scored both on a 5-point (PFS-16polytomous) and on a 2-point scale (PFS-16dichotomous). Results: All scales showed an adequate overall Rasch model fit, high reliability, and good discriminant, convergent, and concurrent validity, but were less accurate in measuring very high and very low fatigue levels. No evidence of differential item functioning with respect to age, sex, and severity of parkinsonian symptoms was found. Some items of FSS-9 (item 1), PFS-16polytomous (items 1 and 13), and PFS-16dichotomous (items 1, 8, and 13) showed misfit, possibly due to their content concerning sleep and motivation disorders. When FSS-9 and PFS-16polytomous' responses were rescored on a 3-point scale, the discriminability across response categories improved. The optimal cut-off score in detecting clinically-diagnosed fatigue (observed in 20% of the sample) was 3.09 for PFS-16polytomous, 8.00 for PFS-16dichotomous, and 4.67 for FSS-9. Conclusions: The Italian version of PFS-16 and FSS-9 showed sound psychometric properties and can be confidently used to quantify fatigue symptoms in PD, although clinical diagnosis of fatigue should rely on validated criteria. The PFS-16polytomous exhibited advantages with respect to PFS-16dichotomous.
引用
收藏
页码:105 / 110
页数:6
相关论文
共 50 条
  • [21] Parkinson's disease and fatigue
    Yoshii, Fumihito
    Takahashi, Hirohide
    Kumazawa, Ryuya
    Kobori, Satoko
    JOURNAL OF NEUROLOGY, 2006, 253 (Suppl 7) : 48 - 53
  • [22] Fatigue in Parkinson's disease
    Torgan, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 326 - 326
  • [23] Parkinson’s disease and fatigue
    Fumihito Yoshii
    Hirohide Takahashi
    Ryuya Kumazawa
    Satoko Kobori
    Journal of Neurology, 2006, 253 : vii48 - vii53
  • [24] Fatigue in Parkinson’s disease
    A. Zenzola
    G. Masi
    M. De Mari
    G. Defazio
    P. Livrea
    P. Lamberti
    Neurological Sciences, 2003, 24 : 225 - 226
  • [25] Fatigue in Parkinson's Disease
    Kluger, Benzi M.
    NONMOTOR PARKINSON'S: THE HIDDEN FACE: THE MANY HIDDEN FACES, 2017, 133 : 743 - 768
  • [26] Fatigue in Parkinson's Disease
    Patel, Bhavana
    Pahwa, Rajesh
    Lyons, Kelly
    NEUROLOGY, 2017, 88
  • [27] Fatigue in Parkinson's Disease
    Homayoun, Houman
    Stebbins, Glenn
    Tilley, Barbara
    Goetz, Christopher
    NEUROLOGY, 2012, 78
  • [28] Fatigue in Parkinson's disease
    Friedman, Joseph H.
    Abrantes, Ana
    Sweet, Lawrence H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (13) : 1999 - 2007
  • [29] Fatigue in Parkinson's disease
    Friedman, J. H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S14 - S15
  • [30] Fatigue in Parkinson's disease
    Lokominiene, R. Kaladyte
    Budrys, V.
    Audronyte, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 671 - 671